← All trials
NCT06351332
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2024
- Primary completion
- Mar 1, 2027
- Completion date
- Sep 1, 2029
- First posted
- Apr 8, 2024
- Last posted
- Sep 19, 2024
- Enrollment
- 78
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Harvard UniversityLead sponsor
- Zentalis PharmaceuticalsCollaborator
- Harvard UniversitySponsor investigator
- Harvard UniversityOfficial
- MerckCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.